share_log

默克公司将停产治疗细菌感染的药物

Merck & Co. will cease production of a drug for treating bacterial infections.

Breakings ·  Dec 23, 2024 23:39

The USA Food and Drug Administration website showed on Monday that Merck & Co. will stop production of a drug that treats a bacterial infection which can cause deadly diarrhea. The antibody drug Zinplava was first approved by regulatory authorities in 2016 for the prevention of recurrent Clostridium difficile infection (CDI). CDI is generally caused by prolonged use of antibiotics and can lead to fatal diarrhea and colitis.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment

    Statement

    This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.